Stephen M G Gottschalk

Title: Innovations and Contributions of Stephen M G Gottschalk

Introduction

Stephen M G Gottschalk is a prominent inventor based in Houston, TX, known for his significant contributions to the field of immunotherapy. With a total of six patents to his name, he has made remarkable advancements in enhancing the efficacy of immune cell therapies.

Latest Patents

Among his latest patents, one notable invention is related to constitutively active cytokine receptors for cell therapy. This patent outlines methods and compositions aimed at enhancing the expansion of immune cells for immunotherapy. Specifically, it describes how immune cells, such as T-cells, can express a constitutively active cytokine receptor that provides an activating signal independently from any input to the corresponding exodomain. Another significant patent involves Car T-cells that recognize cancer-specific IL 13Ra2. This invention provides specific binding molecules that target an epitope of IL13Rα2, which is preferentially found on cancer cells. These binding molecules can be utilized in various therapeutic applications, including the treatment of solid tumor diseases like glioblastoma multiforme.

Career Highlights

Stephen has had a distinguished career, working with esteemed institutions such as Baylor College of Medicine and the University of Chicago. His work has focused on developing innovative therapies that leverage the immune system to combat cancer.

Collaborations

Throughout his career, Stephen has collaborated with notable colleagues, including Thomas C T Shum and Robert Layne Kruse. These collaborations have contributed to the advancement of research in immunotherapy and cancer treatment.

Conclusion

Stephen M G Gottschalk's innovative work in the field of immunotherapy has led to significant advancements in cancer treatment. His patents reflect a commitment to enhancing the capabilities of immune cells, paving the way for more effective therapies.